Chase C. Leavitt - 12 Apr 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
General Counsel/Secretary
Signature
/s/Chase C. Leavitt
Issuer symbol
N/A
Transactions as of
12 Apr 2023
Net transactions value
+$7,250
Form type
4
Filing time
14 Apr 2023, 06:00:16 UTC
Previous filing
23 Feb 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $4,350 +15,000 +18% $0.2900 96,901 12 Apr 2023 Direct
transaction ONCT Common Stock Purchase $2,900 +10,000 +10% $0.2900 106,901 13 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.